Fenretinide in Preventing Ovarian Cancer in Participants Who Are at High Risk for Developing Ovarian Cancer and Planning to Undergo Surgery to Remove the Ovaries
Completed · Not applicable
Conditions studied: brca1 Mutation Carrier, brca2 Mutation Carrier, Ovarian Cancer
In brief
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of fenretinide may prevent ovarian cancer. PURPOSE: This randomized clinical trial is studying how well fenretinide works in preventing ovarian cancer in participants who are at high risk of developing ovarian cancer and planning to undergo surgery to remove the ovaries.
Key facts
- Study ID
- NCT00098800
- Run by
- University of Arizona
- People needed
- 40
- Starts
- 2004-10-01
- Expected to finish
- 2006-11-01
- Last updated by the study team
- 2010-03-24
Who can join
Age: 30 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Arizona Cancer Center at University of Arizona Health Sciences Center — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.